SentiSense
Ctrl+K
Quick tip: Press
to search stocks
Z
ZTS
Zoetis Inc.
$121.43
-0.80 (-0.65%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$121.43
Live market price
P/E (TTM)
20.17
EPS: $6.02
P/S (TTM)
5.41
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 5:56:38 AM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
16.3M
% of Float
4.0%
Days to Cover
3.2
Avg Daily Vol
5.1M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
2.97
Leverage ratio
ROE (TTM)
80.25%
Return on equity
Income Statement
Revenue
$9.47B
Cost of Revenue
$2.67B
Gross Profit
$6.80B
Operating Income
$3.36B
Net Income
$2.67B
EPS (Quarter)
$6.02
EPS (TTM)
--
Balance Sheet
Total Assets
$15.47B
Total Liabilities
$12.14B
Shareholders' Equity
$3.33B
Current Assets
$6.77B
Current Liabilities
$2.23B
Cash & Equivalents
--
Long-Term Debt
--
Cash Flow
Operating Cash Flow
$2.90B
Investing Cash Flow
$-748.00M
Financing Cash Flow
$-1.87B
Free Cash Flow
$2.16B
Profitability Margins
Gross Margin
71.84%
Operating Margin
35.49%
Net Profit Margin
28.23%
ROA (TTM)
17.28%
ROE (TTM)
80.25%
Data source: Polygon.io
Last updated: 3/8/2026, 5:56:38 AM
Company Profile
Symbol
ZTS
Market Cap
$51.26B
IPO Date
Feb 1, 2013
CEO
--
Employees
14,500
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read More